Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
Thomas Pincez, Adjunct Professor at McGill University, Assistant Professor at University of Montreal, Clinician-Scientist at Azrieli Research Centre of CHU Sainte-Justine, shared a post on LinkedIn about recent articles he and his colleagues co-authored, adding:
“Two reviews on current sickle cell disease challenges: Gene therapy and Cancer risk.
Thanks for this great work within RED.”
Title: The Journey of Gene Therapy in Sickle Cell Disease: How Molecular Advances Meet Clinical Care
Authors: Magalie Tardif, Manon Saby, Stéphanie Forté, Thomas Pincez
Read the Full Article on Cells.
Title: Should Sickle Cell Disease Be Considered a Cancer Predisposition Syndrome?
Authors: Elise Casadessus, Yves Pastore, Thomas Pincez
Read the Full Article on Children.
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 13, 2026, 14:54Kalyan Roy: Understanding Blood Transfusion Sets for Safe Clinical Administration
-
Oct 13, 2026, 14:52Chedia Aroua: When Pharmacokinetics Meets Geophysics – Finding Unlikely Connections in Hemophilia Care
-
Oct 13, 2026, 14:47Mehmet Can Uğur: Honored by the Presence and Mentorship of Prof. Dargaud at Our Congress
-
Oct 13, 2026, 14:40Cheryl Loetscher: This Day in Drug Discovery – Wakix and H3 Receptor Inverse Agonism in Narcolepsy
-
Oct 13, 2026, 14:30Thirunavukkarasu Angappan: FVIII vs. FIX Expressive Durability – Key Lessons from GENEr8-1 and HOPE-B Long-Term Data
-
Oct 13, 2026, 14:25Alyaa Al-Mughairy: Highlights from the 8th Omani Society of Hematology Congress
-
Oct 13, 2026, 14:21Britta Diebel: Reflections on an Unforgettable International Plasma Awareness Week
-
Oct 13, 2026, 14:14ESPHO at MAX Cancer Congress 2026: Advancing Ethiopian Pediatric Oncology on the Global Stage
-
Oct 13, 2026, 14:05Antonella Cordoba: WFH Representatives Visit the Hemophilia Foundation of Argentina